# Effectiveness and Safety of Lidocaine for Scleroderma

> **NCT00740285** · PHASE2,PHASE3 · COMPLETED · sponsor: **Federal University of São Paulo** · enrollment: 26 (actual)

## Conditions studied

- Scleroderma

## Interventions

- **DRUG:** Lidocaine 2% without vessel constrictor
- **OTHER:** Placebo - physiological solution 0,9%

## Key facts

- **NCT ID:** NCT00740285
- **Lead sponsor:** Federal University of São Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2006-04
- **Final completion:** 2007-04
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2008-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00740285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00740285, "Effectiveness and Safety of Lidocaine for Scleroderma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00740285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*